Pediatrix Medical Group, Inc.
US ˙ NYSE ˙ US58502B1061

SecurityMD / Pediatrix Medical Group, Inc.
InstitutionMackenzie Financial Corp
Latest Disclosed Ownership0 shares
Latest Disclosed Value $ 0
Mackenzie Financial Corp closes position in MD / Pediatrix Medical Group, Inc.

On May 13, 2026 - Mackenzie Financial Corp filed a 13F-HR form disclosing ownership of 0 shares of Pediatrix Medical Group, Inc. (US:MD) valued at $0 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 18, 2026 disclosing 55,150 shares of Pediatrix Medical Group, Inc.. The current value of the position is $0 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-13 2026-03-31 13F PEDIATRIX MEDICAL GROUP COM 58502B106 0 -100.00 0
2026-02-18 2025-12-31 13F PEDIATRIX MEDICAL GROUP COM 58502B106 55,150 14,502 35.68 1,201 76.62 0.0014
2025-11-13 2025-09-30 13F PEDIATRIX MEDICAL GROUP COM 58502B106 40,648 40,648 681 0.0008
2025-08-13 2025-06-30 13F PEDIATRIX MEDICAL GROUP COM 58502B106 0 -38,399 -100.00 0 -100.00
2025-05-07 2025-03-31 13F PEDIATRIX MEDICAL GROUP COM 58502B106 38,399 17,376 82.65 556 102.18 0.0008
2025-05-02 2024-12-31 13F/A-2 PEDIATRIX MEDICAL GROUP COM 58502B106 21,023 21,023 276 0.0004
2025-02-20 2024-12-31 13F/A-1 PEDIATRIX MEDICAL GROUP COM 58502B106 21,023 21,023 276 0.0004
2025-02-14 2024-12-31 13F Pediatrix Medical Group Common Stock 58502B106 21,023 21,023 194 0.0003
2024-05-10 2024-03-31 13F PEDIATRIX MEDICAL GROUP COM 58502B106 0 -17,766 -100.00 0 -100.00
2024-01-30 2023-12-31 13F PEDIATRIX MEDICAL GROUP COM 58502B106 17,766 -2,059 -10.39 165 -34.26 0.0002
2023-10-25 2023-09-30 13F PEDIATRIX MEDICAL GROUP COM 58502B106 19,825 0 0.00 252 -9.06 0.0004
2023-08-03 2023-06-30 13F PEDIATRIX MEDICAL GROUP COM 58502B106 19,825 19,825 276 0.0004
2022-05-13 2022-03-31 13F MEDNAX COM 58502B106 0 -11,050 -100.00 0 -100.00
2022-02-14 2021-12-31 13F MEDNAX COM 58502B106 11,050 -1,353 -10.91 301 -14.73 0.0004
2021-11-08 2021-09-30 13F MEDNAX COM 58502B106 12,403 1,355 12.26 353 6.01 0.0005
2021-08-11 2021-06-30 13F MEDNAX COM 58502B106 11,048 2,581 30.48 333 54.17 0.0005
2021-05-14 2021-03-31 13F MEDNAX COM 58502B106 8,467 -779 -8.43 216 -4.85 0.0003
2021-02-10 2020-12-31 13F MEDNAX COM 58502B106 9,246 -754 -7.54 227 39.26 0.0005
2020-11-13 2020-09-30 13F MEDNAX COM 58502B106 10,000 -10,250 -50.62 163 -52.89 0.0004
2020-08-13 2020-06-30 13F MEDNAX COM 58502B106 20,250 -5,900 -22.56 346 13.82 0.0009
2020-05-14 2020-03-31 13F MEDNAX COM 58502B106 26,150 10,800 70.36 304 -28.81 0.0010
2020-02-13 2019-12-31 13F MEDNAX COM 58502B106 15,350 15,350 427 0.0011
2019-08-23 2019-06-30 13F/A-1 MEDNAX COM 58502B106 0 -89,855 -100.00 0 -100.00
2019-05-15 2019-03-31 13F MEDNAX COM 58502B106 89,855 89,855 2,441 0.0059
2018-11-15 2018-09-30 13F MEDNAX COM 58502B106 0 -127,643 -100.00 0 -100.00
2018-08-13 2018-06-30 13F MEDNAX COM 58502B106 127,643 -700 -0.55 5,524 -22.63 0.0141
2018-05-14 2018-03-31 13F/A-1 MEDNAX COM 58502B106 128,343 128,343 7,140 0.0182
2018-05-14 2018-03-31 13F MEDNAX COM 58502B106 128,343 7,140
2017-02-14 2016-12-31 13F MEDNAX COM 58502B106 0 -5,706 -100.00 0 -100.00
2016-11-15 2016-09-30 13F MEDNAX COM 58502B106 5,706 -3,385 -37.23 378 -42.55 0.0024
2016-08-12 2016-06-30 13F MEDNAX COM 58502B106 9,091 123 1.37 658 13.45 0.0037
2016-05-12 2016-03-31 13F MEDNAX COM 58502B106 8,968 73 0.82 580 -8.95 0.0053
2016-02-12 2015-12-31 13F MEDNAX COM 58502B106 8,895 6,004 207.68 637 186.94 0.0040
2015-11-13 2015-09-30 13F MEDNAX COM 58502B106 2,891 2,891 222 0.0013
2013-11-12 2013-09-30 13F MEDNAX COM 58502B106 0 -11,200 -100.00 0 -100.00
2013-08-20 2013-06-30 13F/A-1 MEDNAX COM 58502B106 11,200 11,200 1,026 0.0049
2013-08-09 2013-06-30 13F MEDNAX COM 58502B106 11,200 1,026 0.0049
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.